GANNON STEVEN · Xenon Pharmaceuticals Inc. · 2h agono track record yet
Sold 10,000 @ $64.06 avg · $640,550 · 2026-08-11
Form 4: GANNON STEVEN sold XENE
GANNON STEVEN (Director at Xenon Pharmaceuticals Inc.) reported an open-market sale of 10,000 shares of XENE at an average $64.06, roughly $640,550, in a Form 4 filed 2026-08-13.